Business Investors flee COVID pill drugmaker on news of birth defect risk Published 3 years ago on 13 April 2022 By Terry Power Share Tweet Shionogi COVID pill: Investors flee drugmaker on news of birth defect risk | Fortune You need to enable JavaScript to view this site. Related Topics:BirthCOVIDdefectdrugmakerfleeinvestorsNewsPillrisk Up Next NBA star James Harden on why he invested in The Beard Club Don't Miss Boris Johnson’s ‘partygate’ fine probably won’t cause the British prime minister to resign. But it could still plunge the U.K. into crisis Continue Reading You may like The Download: counting China’s mpox cases, and Meta has blocked news in Canada Decoding the data of the Chinese mpox outbreak China is suddenly dealing with another public health crisis: mpox Covid hasn’t entirely gone away—here’s where we stand Exercise Can Increase Stroke Risk In People With Blocked Arteries, Study Shows Meta’s AI leaders want you to know fears over AI existential risk are “ridiculous” Business These fast-growing Sun Belt cities suffer from high inflation Published 3 years ago on 4 May 2022 By Terry Power U.S. migration hotspots tend to have the highest inflation | Fortune You need to enable JavaScript to view this site. Continue Reading Business The U.S. is seizing a $325 million helipad-equipped megayacht in Fiji. The question is which Russian oligarch it belongs to Published 3 years ago on 4 May 2022 By Terry Power Oligarch sanctions: U.S. seizing $325 million megayacht in Fiji. The question is which Russian billionaire it belongs to | Fortune You need to enable JavaScript to view this site. Continue Reading Business Investors bank on today’s ‘once-in-a-generation’ Fed hike to be one of several Published 3 years ago on 4 May 2022 By Terry Power Fed rate hike: decision day rattles markets as investors worry that a giant ‘once-in-a-generation’ hike will be one of several this year | Fortune You need to enable JavaScript to view this site. Continue Reading